Trial Outcomes & Findings for Quality Control: A Prospective Analysis of EVD Effectiveness (NCT NCT02484287)
NCT ID: NCT02484287
Last Updated: 2023-07-03
Results Overview
Infection rates of EVD patients
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
60 participants
Primary outcome timeframe
24 months
Results posted on
2023-07-03
Participant Flow
Participant milestones
| Measure |
Ventriclear EVD Antibiotic Catheter
The Ventriclear EVD Antibiotic Catheter antibiotic-impregnated EVD catheter
The Ventriclear EVD Antibiotic Catheter: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
Integra External Drainage Catheter
The Integra External Drainage Catheter non antibiotic-impregnated EVD catheter
The Integra External Drainage Catheter.: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
Codman Bactiseal EVD Catheter Set
The Codman Bactiseal EVD Catheter Set antibiotic-impregnated EVD catheter
The Codman Bactiseal EVD Catheter Set: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
|---|---|---|---|
|
Overall Study
STARTED
|
15
|
26
|
19
|
|
Overall Study
COMPLETED
|
0
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
15
|
26
|
19
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Quality Control: A Prospective Analysis of EVD Effectiveness
Baseline characteristics by cohort
| Measure |
Ventriclear EVD Antibiotic Catheter
n=15 Participants
The Ventriclear EVD Antibiotic Catheter antibiotic-impregnated EVD catheter
The Ventriclear EVD Antibiotic Catheter: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
Integra External Drainage Catheter
n=26 Participants
The Integra External Drainage Catheter non antibiotic-impregnated EVD catheter
The Integra External Drainage Catheter.: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
Codman Bactiseal EVD Catheter Set
n=19 Participants
The Codman Bactiseal EVD Catheter Set antibiotic-impregnated EVD catheter
The Codman Bactiseal EVD Catheter Set: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
Total
n=60 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
9 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
38 Participants
n=4 Participants
|
|
Age, Categorical
>=65 years
|
5 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
21 Participants
n=4 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
31 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
29 Participants
n=4 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Black or African American
|
3 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
8 Participants
n=4 Participants
|
|
Race (NIH/OMB)
White
|
10 Participants
n=5 Participants
|
21 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
43 Participants
n=4 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
|
Region of Enrollment
United States
|
15 participants
n=5 Participants
|
26 participants
n=7 Participants
|
19 participants
n=5 Participants
|
60 participants
n=4 Participants
|
PRIMARY outcome
Timeframe: 24 monthsInfection rates of EVD patients
Outcome measures
| Measure |
Ventriclear EVD Antibiotic Catheter
n=15 Participants
The Ventriclear EVD Antibiotic Catheter antibiotic-impregnated EVD catheter
The Ventriclear EVD Antibiotic Catheter: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
Integra External Drainage Catheter
n=26 Participants
The Integra External Drainage Catheter non antibiotic-impregnated EVD catheter
The Integra External Drainage Catheter.: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
Codman Bactiseal EVD Catheter Set
n=19 Participants
The Codman Bactiseal EVD Catheter Set antibiotic-impregnated EVD catheter
The Codman Bactiseal EVD Catheter Set: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
|---|---|---|---|
|
Infection Rates of EVD Patients
|
0 Participants
|
0 Participants
|
0 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 Monthsduration of EVD placement in days
Outcome measures
| Measure |
Ventriclear EVD Antibiotic Catheter
n=26 Participants
The Ventriclear EVD Antibiotic Catheter antibiotic-impregnated EVD catheter
The Ventriclear EVD Antibiotic Catheter: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
Integra External Drainage Catheter
n=15 Participants
The Integra External Drainage Catheter non antibiotic-impregnated EVD catheter
The Integra External Drainage Catheter.: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
Codman Bactiseal EVD Catheter Set
n=19 Participants
The Codman Bactiseal EVD Catheter Set antibiotic-impregnated EVD catheter
The Codman Bactiseal EVD Catheter Set: Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.
|
|---|---|---|---|
|
Duration of EVD Placement
|
11 days
Standard Deviation 7
|
13 days
Standard Deviation 10
|
10 days
Standard Deviation 5
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 monthsPopulation: This data was not collected and is no longer available.
Comparable cost of each device
Outcome measures
Outcome data not reported
Adverse Events
Integra External Drainage Catheter
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Ventriclear EVD Antibiotic Catheter
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Codman Bactiseal EVD Catheter Set
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place